Involvement of dopamine system in regulation of Na+,K +-ATPase in the striatum upon activation of opioid receptors by morphine

Molecular Pharmacology

Volumn 71, Issue 2, 2007, Pages 519-530

  Wu, Zhao Qiu ^a,b   Chen, Jie ^a   Chi, Zhi Qiang ^a   Liu, Jing Gen ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b Purdue University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE RECEPTOR; ENZYME ACTIVATOR; ETICLOPRIDE; MORPHINE; N 6,2' O DIBUTYRYLADENOSINE 3',5' CYCLIC MONOPHOSPHATE SODIUM; NALTREXONE; OPIATE RECEPTOR; QUINPIROLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN CHEMISTRY; CORPUS STRIATUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG TOLERANCE; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; NA(+)-K(+)-EXCHANGING ATPASE; NARCOTIC ANTAGONISTS; PHOSPHORYLATION; RECEPTORS, DOPAMINE; RECEPTORS, OPIOID;

EID: 33846403729     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029561     Document Type: Article

References (46)

1. +-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci USA 88:11359-11362.
2. 2 dopamine receptor synergism. Nature (Lond) 347:386-388.
3. +-ATPase alpha-subunit distribution and abundance in guinea-pig longitudinal muscle/myenteric plexus after exposure to morphine. Brain Res 931:186-193.
4. Bontempi B and Sharp FR (1997) Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J Neurosci 17:8596-8612.
5. Chartoff EH, Papadopoulou M, Konradi C, Carlezon Jr WA (2003) Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. J Neurochem 87:107-118.
6. +-ATPase activity is not associated with internalization of the enzyme. Acta Physiol Scand 164:39-46.
7. +-ATPase in response to beta-adrenergic hormone. Am J Physiol 273:C893-C901.
8. Di Chiara G and North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13:185-193.
9. +-ATPase: molar and specific activity, protein determination. Meth Enzymol 156:105-115.
10. Fienberg AA, Hiroi N, Mermelstein P, Song WJ, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, , , et al. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (Wash DC) 281:838-842.
11. Georges F, Stinus L, Block B, and Le Moine C (1999) Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci 11:481-490.
12. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (Wash DC) 250:1429-1432.
13. Gould TD and Manji HK (2005) DARPP-32: A molecular switch at the nexus of reward pathway plasticity. Proc Natl Acad Sci USA 102:253-254.
14. Graybiel AM, Moratalla R, and Robertson HA (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87:6912-6916.
15. Greengard P, Nairn AC, Girault J-A, Ouimet CC, Snyder GL, Fisone G, Allen PB, Fienberg A, and Nishi A (1998) The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Res Rev 26:274-284.
16. 2 signaling by nicotine in neostriatal neurons. J Neurochem 90:1094-1103.
17. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature (Lond) 371:155-157.
18. Hyman SE, Malenka RC, and Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598.
19. Johnson SW and North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
20. Kong J-Q, Leedham JA, Taylor DA, and Fleming W W (1997) Evidence that tolerance and dependence of guinea pig myenteric neurons to opioids is a function of altered electrogenic sodium-potassium pumping. J Pharmacol Exp Ther 280:593-599.
21. Kong J-Q, Meng J, Biser PS, Fleming WW, and Taylor DA (2001) Cellular depolarization of neurons in the locus ceruleus region of the guinea pig associated with the development of tolerance to opioids. J Pharmacol Exp Ther 298:909-916.
22. Koob GF (1992) Neural mechanisms of drug reinforcement. Ann NY Acad Sci 654:171-191.
23. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
24. Liu J-G and Anand KJS (2001) Protein kinase modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev 38:1-19.
25. +-ATPase. Brain Res 957:311-319.
26. +-ATPase. J Neurosci 11:381-391.
27. Missale C, Nash SR, Robbinson SW, Jaber M, and Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
28. 1 dopamine receptors modulate ΔfosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314:148-154.
29. 2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice. Pharmacol Biochem Behav 43:603-608.
30. Nestler EJ and Tallman JF (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol 33:127-132.
31. +-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J Neurochem 73:1492-1501.
32. Pinto Ferreia M, Delucia R, Luiz Aizenstein M, and Glezer I (1998) Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum. J Neural Transm 105:549-560.
33. Pontieri FE, Tanda G, and Di Chiara (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308.
34. Pothos E, Rada P, Mark GP, and Hoebel BG (1991) Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566:348-350.
35. Pu L, Bao G-B, Xu N-J, Ma L, and Pei G (2002) Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 22:1914-1921.
36. Robbins TW and Everitt BJ (1999) Drug addiction: bad habits add up. Nature (Lond) 398:567-570.
37. Roth BL, Laskowaki MB, and Coscia CJ (1981) Evidence for distinct subcellular sites of opiate receptors. J Biol Chem 256:10117- 10123.
38. Sharma P, Kaur G, Bhardwaj SK, and Kaur G (1998) Role of opioidergic and monoaminergic neurotransmission in the GnRH release mechanism of EBPprimed OVX rats. Brain Res Bull 47:81-86.
39. +-ATPase via a selective effect on the α3 isozyme. Proc Natl Acad Sci USA 93:8034-8039.
40. Taylor DA and Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11-18.
41. 2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacol Biochem Behav 81:887-893.
42. Terwilliger RZ, Beitner-Johnson D, Sevarino K, Crain SM, and Nestler EJ (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110.
43. Van Vliet B, De Vries TJ, Wardeh G, Mulder AH, and Schoffelmeer AN (1991) mu-opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur J Pharmacol 208:105-111.
44. Wickens JR, Reynolds JNJ, and Hyland B (2003) Neural mechanisms of reward-related motor learning. Curr Opin Neurobiol 13:685-690.
45. +-ATPase upon activation of opioid receptors by morphine. Mol Pharmacol 69:866-876.
46. - cells, Mol Pharmacol 46:373-378.